According to Catalyst Pharmaceuticals's latest financial reports and stock price the company's current number of shares outstanding is 106,568,137. At the end of 2023 the company had 106,568,137 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.10 B | 1.9% |
2022 | 0.10 B | 1.43% |
2021 | 0.10 B | -0.57% |
2020 | 0.10 B | 0.5% |
2019 | 0.10 B | 0.43% |
2018 | 0.10 B | 12.34% |
2017 | 91.45 M | 10.32% |
2016 | 82.89 M | 0.13% |
2015 | 82.79 M | 23.26% |
2014 | 67.16 M | 50.31% |
2013 | 44.68 M | 39.07% |
2012 | 32.13 M | 48.39% |
2011 | 21.65 M | 15.05% |
2010 | 18.82 M | 33.82% |
2009 | 14.06 M | 9.35% |
2008 | 12.86 M | 2.68% |
2007 | 12.52 M | 78.44% |
2006 | 7.02 M | 13.14% |
2005 | 6.2 M | 112.61% |
2004 | 2.91 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 2,407,200,000 | 2,158.84% | ๐บ๐ธ USA |
Pfizer PFE | 5,647,000,000 | 5,198.96% | ๐บ๐ธ USA |
Abbott Laboratories ABT | 1,734,076,358 | 1,527.20% | ๐บ๐ธ USA |
Sarepta Therapeutics
SRPT | 88,889,000 | -16.59% | ๐บ๐ธ USA |
Acorda Therapeutics
ACOR | 1,242,000 | -98.83% | ๐บ๐ธ USA |
BioMarin Pharmaceutical BMRN | 188,219,000 | 76.62% | ๐บ๐ธ USA |